About Enterprise Partners Venture Capital
Enterprise Partners Venture Capital is a venture capital firm founded in 1985. It is primarily based out of San Diego, United States. As of Aug 2010, Enterprise Partners Venture Capital has invested in 29 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and High Tech. Most recently it participated in the $***** Series E round of Complete Genomics Overall, Enterprise Partners Venture Capital portfolio has seen 2 IPOs and 16 acquisitions including key companies like Xifin, NuVasive and Complete Genomics. A lot of funds co-invest with Enterprise Partners Venture Capital, with names like Kleiner Perkins sharing a substantial percentage of its portfolio. Enterprise Partners Venture Capital has team of 4 people including 3 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series C & 2 more
Portfolio Acquisitions
Enterprise Partners Venture Capital's List of Top Investments
Enterprise Partners Venture Capital has a portfolio of 29 companies. Their most notable investments are in Complete Genomics and Ascenta.Their portfolio spans across and United States. They have invested in Enterprise Applications, Life Sciences, High Tech and 10 other sectors, across stages such as Series B, Series C and 2 more. Here is the list of top investments by Enterprise Partners Venture Capital:1. Xifin
Xifin is a cloud-based billing & revenue cycle management solutions for diagnostic service providers. It features a business intelligence platform to link healthcare stakeholders in the delivery and reimbursement of care and optimizes both business and patient outcomes. It offers to increase in patient payments, reduces errors in billing data, improves staff productivity and streamline revenue cycle management, enhances patient satisfaction, and reduce bad debt and billing costs.
Key facts about Xifin
- Founded Year: 1997
- Location: San Diego (United States)
- Stage: Acquired
- Total Funding till date: $6M
- Employee Count: 721 as on Sep 30, 2026
- Investors: Goldman Sachs, Enterprise Partners Venture Capital and 5 Others
- Latest Funding Round: Series B, Sep 03, 2025, $*****
- Highlight: Acquired
2. NuVasive
Developer of smart surgical devices for spinal surgery. The company has seven products on the market, including stem cell-based Osteocel. Went public in 2012. In Jan 2016, acquired Ellipse Technologies, another orthopedic surgical device maker. The company has developed the NVM5 used for intraoperative neuromonitoring during surgery.
Key facts about NuVasive
- Founded Year: 1997
- Location: San Diego (United States)
- Annual Revenue: $1B+ as on Dec 31, 2022
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $54.1M
- Employee Count: 1,395 as on Sep 30, 2026
- Investors: Enterprise Partners Venture Capital, Domain Associates and 6 Others
- Latest Funding Round: Post IPO, May 26, 2020, $*****
- Highlight: Acquired
Complete Genomics is a developer of DNA sequencing platform for human genome sequencing and analysis. It has developed a DNA sequencing platform based on its proprietary DNA nanoball sequencing technology. It is a method of rolling cycle replication to clonally amplify small fragments of DNA into DNA nanoballs which are then attached to a microarray flow cell and sequenced. The sequencing generates fragment lengths of 250-500 bp (mate pair distance), which can then be analyzed using proprietary algorithms. The company's platform is called the Revolocity Platform and is optimized for the Human whole genome and whole exome sequencing. The company also provides analysis and data management software for generating finished variant reports and assemblies.
Key facts about Complete Genomics
- Founded Year: 2006
- Location: San Jose (United States)
- Annual Revenue: $10M - $50M as on Dec 31, 2011
- Stage: Acquired
- Total Funding till date: $125M
- Employee Count: 237 as on Sep 30, 2026
- Investors: Enterprise Partners Venture Capital, Orbimed and 8 Others
- Latest Funding Round: Series E, Aug 19, 2010, $*****
- Highlight: Acquired
4. Celladon
Telecommunications solutions provider empowering connectivity through innovation and future-ready technology. The company delivers impactful and reliable telecommunications solutions. Specializing in telegraphy, satellite communications, and telephony, it pioneers trends in the telecommunications sector, offering services from mobile connectivity to secure transactions. It provides cutting-edge solutions, including next-generation mobile networks, AI, and IoT, ensuring accessibility and reliability. VoIP solutions redefine traditional telephony, offering cost-effective, scalable, and cloud-based communication for businesses. The company harnesses IoT data for efficiency, innovation, and smarter decision-making. Blockchain technology enhances the safety of every digital interaction. It delivers fixed VoIP telephony and designs reliable connectivity, tailoring each project to meet specific needs. The company is committed to digital success, navigating the future of telecommunications with confidence.
Key facts about Celladon
- Founded Year: 2000
- Location: San Diego (United States)
- Annual Revenue: $10M - $50M as on Dec 31, 2023
- Stage: Public
- Total Funding till date: $117M
- Employee Count: 56 as on Dec 31, 2022
- Investors: Lundbeck Foundation, Enterprise Partners Venture Capital and 13 Others
- Latest Funding Round: Post IPO, Nov 18, 2015, $*****
- Highlight: Public
5. PathScale
Pathscale develops highly optimizing compiler for the x86-64 microprocessor architectures. Its offerings include Fortran, C and C++ compiler products for AMD64, Intel 64, MIPS processors. It provides the PathScale EKOPath Compiler Suite which is claimed to have the world's most advanced optimization infrastructure and can exploit the potentials of many-core architectures. Its compilers are tailored for clustered, GPGPU and multi-core computing environments. The company has been acquired and sold multiple times with players like QLogic, SiCortex and Cray before being bought by the new entity.
Key facts about PathScale
- Founded Year: 2002
- Location: Wilmington (United States)
- Stage: Acquired
- Total Funding till date: $30M
- Employee Count: 6 as on Sep 30, 2026
- Investors: Adams Street Partners, Enterprise Partners Venture Capital and 7 Others
- Latest Funding Round: Series C, Dec 2005, $*****
- Highlight: Acquired
Enterprise Partners Venture Capital's Investments by Stage
Enterprise Partners Venture Capital has made 14 investments in Series B stage with an average round size of $18.5M, 7 investments in Series C stage with an average round size of $16.2M, 5 investments in Series A stage with an average round size of $5.56M and 1 investment in Angel stage.Stage of entry | No. of Investments |
|---|---|
Series B | 14 |
Series C | 7 |
Series A | 5 |
Angel | 1 |
Note: We have considered here, only first round of investments
Enterprise Partners Venture Capital's Investments by Sector
Enterprise Partners Venture Capital has a diverse portfolio, with companies operating in the Enterprise Applications, Life Sciences, Enterprise Infrastructure, High Tech and Semiconductors. Notably, it has invested in 24 Enterprise (B2B) companies, 23 Tech companies, 14 Software companies and at least 5 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 10 |
Life Sciences | 6 |
Enterprise Infrastructure | 4 |
High Tech | 4 |
Semiconductors | 4 |
Others | 16 |
Note: We have considered here, only first round of investments
Enterprise Partners Venture Capital's Investments by Geography
Enterprise Partners Venture Capital has made most investments in United States (27).Enterprise Partners Venture Capital's recent investments
Enterprise Partners Venture Capital has not made any investment in 2026 so far.Here are the most recent investments by Enterprise Partners Venture Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Aug 19, 2010 | United States | Series E | 4328 | ||
May 18, 2010 | United States | Series B | 5943 | [+3] | |
Nov 10, 2009 | United States | Series D | 2982 | ||
Nov 01, 2009 | United States | Series C | 1498 | [+1] | |
Oct 01, 2009 | United States | Series B | 1391 | [+2] |
IPOs and Publicly Listed companies in Enterprise Partners Venture Capital's Portfolio
2 of Enterprise Partners Venture Capital's portfolio companies have become public. Celladon got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jan 2014 at marketcap of $214M.Here are Enterprise Partners Venture Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 30, 2014 | Dec 06, 2005 | Series B | 6465 | |
- | May 03, 2006 | Series B | 3029 |
Acquired companies in Enterprise Partners Venture Capital's Portfolio
16 companies from Enterprise Partners Venture Capital's portfolio have been acquired. The most recent acquisition was Complete Genomics in Feb 2026 by Swiss Rockets for $*****.Here are Enterprise Partners Venture Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 23, 2026 | Mar 31, 2008 | Series C | 4184 | |
Feb 09, 2023 | May 22, 2001 | Series C | 2648 | |
Apr 25, 2022 | Mar 16, 2007 | Series C | 3011 | |
Jan 22, 2020 | 2003 | Angel | 8204 | |
May 08, 2019 | Mar 14, 2005 | Series B | 3074 |
Team profile of Enterprise Partners Venture Capital
Enterprise Partners Venture Capital has a team of 4 members including 3 Partners located in United States. Enterprise Partners Venture Capital's team does not sit on the board of any company as of now.Here is a list of all team members in Enterprise Partners Venture Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | San Diego | - | ||
Partner | San Diego | - | - | |
Partner | - | - | - |
Co-investors of Enterprise Partners Venture Capital
Over the past 26 years, 106 investors have co-invested in Enterprise Partners Venture Capital's portfolio companies. This includes only funds.
- Invested before Enterprise Partners Venture Capital: Wall Street Technology Partners, Oak Investment Partners and 6 others have invested in rounds before Enterprise Partners Venture Capital. There is 1 company where Wall Street Technology Partners has invested before Enterprise Partners Venture Capital and 1 company where Oak Investment Partners has invested before Enterprise Partners Venture Capital.
- Top Co-investors of Enterprise Partners Venture Capital: 51 investors entered a company along with Enterprise Partners Venture Capital. These include investors like Kleiner Perkins (4 companies).
- Invested after Enterprise Partners Venture Capital: A total of 47 investors have invested in Enterprise Partners Venture Capital's portfolio after their investments. Top Investors include Johnson & Johnson Innovation – JJDC (2 companies), OSTI (2 companies) and Ares Capital Corporation (1 company).
Recent News related to Enterprise Partners Venture Capital
•
Evariant Raises $18.3M in Series B Financing |FinSMEsFinSMEs•May 05, 2014•Evariant, Lightspeed Venture Partners, Dignity Health, Enterprise Partners Venture Capital and 1 other
•
Evariant Raises $18.3 Million in Series B Funding from a Syndicate of Leading SaaS Investors and aPR Newswire•May 02, 2014•Evariant, Lightspeed Venture Partners, Dignity Health, Enterprise Partners Venture Capital and 1 other
•
Evariant Raises $18.3 Million in Funding in Series B | EvariantEvariant•May 02, 2014•Evariant, Lightspeed Venture Partners, Dignity Health, Enterprise Partners Venture Capital and 1 other
•
Domain Knowledge Wins: Larry Goldenhersh, CEO of Enviance (Part 6) | Sramana Mitra1M By 1M•Nov 01, 2011•Enviance, Enterprise Partners Venture Capital
•
Devicescape connects your device to WiFi hotspots | VentureBeatVentureBeat•Jan 30, 2007•Devicescape, August Capital, Applied Materials, Icon Ventures and 2 others
•
Tarari raises $14M, unveils new network chipsSan Diego Union-Tribune•Jan 28, 2006•Tarari, Enterprise Partners Venture Capital, Morgan Stanley, Intel Capital and 2 others
•
PE Week Wire - Friday, July 16 - PE HubPE Hub•Jul 16, 2004•Magink display technologies, VantagePoint Capital Partners, Formula Ventures, Japan Asia Investment and 11 others
•
Hammerhead Systems Secures $25 Million Series B from Mayfield, Foundation Capital, EnterprisePR Newswire•Jan 26, 2004•Hammerhead Systems, Pequot Capital Management, Mayfield, Foundation Capital and 1 other
•
Enviance Raises $10 million - WSJThe Wall Street Journal•Jan 13, 2004•Enviance, Enterprise Partners Venture Capital
•
Enviance Raises $10 Million to Drive GrowthPR Newswire•Jan 13, 2004•Enviance, Enterprise Partners Venture Capital
